Sign In
Buy APTX
$0.0960
+0 (+0%)
At Close: Mar 28, 2024
3 “Strong Buy” Biotech Stocks Trading Under $10
04:24pm, Monday, 04'th May 2020
Wall Street is experiencing some major déjà vu. The tensions between the U.S. and China flared after President Trump threatened to impose new import tariffs. The difference this time? These tariffs
May 04, 2020 (The Expresswire) --
Global "Cognitive and Memory Enhancer Drugs Market" Global report 2020 presents a point by point analysis of the key...
Abbvie stands by 2020 profit forecast as Humira fuels quarterly beat
01:03pm, Friday, 01'st May 2020
AbbVie Inc stuck with its 2020 adjusted profit forecast on Friday after strong demand for its blockbuster rheumatoid arthritis drug, Humira, helped it beat analysts' estimates for quarterly profit and
Consultant says Covid like having terrorist attack twice a day
03:23pm, Thursday, 30'th Apr 2020
The London Economic | We have already started speaking to psychologists who work with other charities in war zones.| Must Reads
Aptinyx to Report First Quarter Financial Results on Thursday, May 14, 2020
12:47pm, Thursday, 30'th Apr 2020
EVANSTON, Ill., April 30, 2020 -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain.
This is what it's like having a mental health condition during coronavirus
05:38pm, Wednesday, 29'th Apr 2020
We spoke to people across Greater Manchester with mental health conditions about how they are coping during lockdown
Analysts Are Bullish on These Healthcare Stocks: Aptinyx (APTX), Iovance Biotherapeutics (IOVA)
11:18am, Wednesday, 29'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Aptinyx (APTX), Iovance Biotherapeutics (IOVA) and
Analysts Are Bullish on These Healthcare Stocks: Aptinyx (APTX), Iovance Biotherapeutics (IOVA)
11:18am, Wednesday, 29'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Aptinyx (
APTX
–
Research Report
), Iovance Biotherapeutics (
IOVA
–
Research Report
) and Blueprin
Morgan Stanley cuts view on Incyte in premarket analyst action
11:06am, Wednesday, 29'th Apr 2020
Aptinyx (NASDAQ:APTX) initiated with Buy rating and $7 (181% upside) price target at H.C. Wainwright.Mersana Therapeutics (NASDAQ:MRSN) initiated with Buy rating and $14 (50% upside) price target at B
The Zacks Analyst Blog Highlights: Airgain, Trilogy Metals, Aptinyx, Veritone and Tufin Software Technologies
01:00pm, Tuesday, 28'th Apr 2020
The Zacks Analyst Blog Highlights: Airgain, Trilogy Metals, Aptinyx, Veritone and Tufin Software Technologies
Will Aptinyx Continue to Surge Higher?
04:08pm, Thursday, 16'th Apr 2020
As of late, it has definitely been a great time to be an investor Aptinyx
Aptinyx Inc. (APTX) Moves to Buy: Rationale Behind the Upgrade
04:00pm, Friday, 03'rd Apr 2020
Aptinyx Inc. (APTX) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Multi-strategy hedge funds outperformed peers as market plunged
08:54pm, Wednesday, 01'st Apr 2020
Multi-strategy hedge funds - those that bet on a broad array of markets using teams of traders, leverage and centralized risk management - have flourished as stocks ended their worst three months sinc
Earnings Update: Aptinyx Inc. (NASDAQ:APTX) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts
06:04pm, Wednesday, 01'st Apr 2020
Shareholders might have noticed that Aptinyx Inc. (NASDAQ:APTX) filed its annual result this time last week. The early...
